Trial · NCT05813665
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Patients With Giant Cell Objective Tumor Response | From enrollment until 12 weeks | |
| Secondary | Percentage of Patients With Giant Cell Objective Tumor Response | Throughout the study period, up to approximately 4 years | |
| Secondary | Disease Control Rate (DCR) | Up to approximately 4 years | |
| Secondary | Time to Response (TTR) | Up to approximately 4 years | |
| Secondary | Duration of Response (DOR) | Up to approximately 4 years | |
| Secondary | Time to Progression (TTP) | Up to approximately 4 years | |
| Secondary | Percentage of Patients Downstaging the Planned Surgical Procedure | From enrollment until surgery, up to approximately 4 years | |
| Secondary | Time to First Tumor Surgery | From enrollment until the first tumor surgery, up to approximately 4 years | |
| Secondary | Changes in Brief Pain Inventory Short Form (BPI-SF) score | From enrollment until the last dose, up to approximately 4 years | |
| Secondary | Types and Proportion of Key Adverse Reactions | From the first dose of study drug until 90 days after the last dose, up to approximately 4 years | |
| Secondary | Serum JMT103 Concentrations | Days 8 of Cycle 1, Day 1 of Cycle 2, 3, 4, 5, 6, and 90 days after the last dose (each cycle is 28 days) | |
| Secondary | Number of Patients with Anti-JMT103 Antibodies | Day 1 of Cycle 1, 2, 4, 6, and 90 days after the last dose (each cycle is 28 days) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05813665/registered